What is an ibogaine session like?

The sequence is more predictable than most accounts suggest. A retrospective series of 33 treatments describes intense effects beginning one to three hours after the dose and lasting about four to eight hours, followed by a longer and quieter state of roughly eight to twenty hours [1]. Insomnia often continues for three days [1].

What is actually documented

Descriptions of ibogaine sessions circulate widely, most of them individual accounts. Two published sources are more useful, because they describe groups rather than single experiences.

The first is a 1999 case series covering 33 heroin-dependent people treated between 1962 and 1993 in the United States and the Netherlands [1]. It is the source of the phase structure most descriptions rely on.

Its setting matters to how it is read. The treatments took place in non-medical settings including hotel rooms and apartments, observed by lay co-authors over 48 to 72 hours [1]. That is a historical record of how ibogaine was used, not a model of how it should be.

The second is the Dutch hospital study of fourteen patients, which recorded physical effects with instruments rather than observation [2]. A qualitative study of thirty veterans adds what people said afterwards [3].

Onset

Intense effects begin one to three hours after swallowing the dose [1].

Blood levels peak sooner than that. In the Dutch cohort, ibogaine reached its peak concentration at a median of about 37 minutes [5], so the subjective onset lags the chemistry by an hour or more.

Protocols often give a small test dose first, two to three milligrams per kilogram in the Stanford study, with the remainder following within two hours [4]. The test dose is a safety step, checking for an unexpected reaction before the full amount is committed.

The first phase: recall

The first state lasts about four to eight hours [1].

Its defining feature is described as panoramic recall of past life events, mostly visual [1]. People report seeing scenes from their own history rather than invented imagery.

The series is explicit that hallucinations were less prominent than these recalled images [1]. That distinguishes ibogaine from how it is often grouped with other psychedelics, where novel visionary content is more typical than autobiographical review.

In the Dutch cohort, patients reported closed-eye visuals and vivid memories, and one reported visual hallucinations [2]. The consistency between a 1999 series and a hospital study decades later is one of the more stable findings in this literature.

Eye shades are commonly used, and in the Stanford protocol participants lay on mats wearing them [3]. The experience is inward rather than interactive.

The second phase: reflection

A second state follows, lasting roughly eight to twenty hours [1].

Images become fewer. Attention shifts to evaluating the material recalled during the first phase, and the tone is described as neutral and reflective [1].

This phase is longer than the first and receives far less attention in popular accounts, which tend to concentrate on the visionary hours. Taken together, the two states occupy most of a day and a night.

The arithmetic matters for anyone picturing this. Four to eight hours of recall followed by eight to twenty hours of reflection means a person is under substantial effects for between twelve and twenty-eight hours, during which they cannot leave or reschedule.

The physical effects

The physical side is less often described and is the part a person is least prepared for.

In the Dutch study, all fourteen patients developed severe transient ataxia and were unable to walk unaided [2]. Loss of coordination is not an occasional side effect but something that happened to everyone in that cohort.

The follow-up analysis found that ataxia tracked ibogaine concentration rather than noribogaine [5], which means it rises and falls with the parent drug.

Nausea and vomiting are common, and drowsiness, nausea and anxiety were among the frequently reported effects in a separate pilot. Vomiting carries its own significance here, since it can lower potassium, and potassium outside the normal range lengthens the QT interval independently [2].

Throughout, continuous cardiac monitoring is running. In the Stanford protocol this ran for twelve to sixteen hours with staff certified in advanced cardiac life support present at a ratio of at least one per two patients [4].

The days after

The session does not end when the effects fade.

Insomnia often lasts 72 hours and responds to sleep medication [1]. Three days without normal sleep is a substantial physical demand on its own, arriving immediately after an exhausting experience.

The cardiac risk also continues past the experience. In the Dutch cohort, six of fourteen still had a QT interval above 450 milliseconds beyond twenty-four hours [2], by which point most of the drug had cleared.

This is why monitoring periods are defined by measurements rather than by how a person feels. Someone can feel finished while the EKG says otherwise.

What veterans in one study described

Thirty veterans wrote about their experience on average about two weeks afterwards, and researchers analysed the accounts [3].

Four themes emerged. Re-encountering and re-appraising traumatic memories, often with love, forgiveness and acceptance. An observer-like or dissolved sense of self, described as mystical connection. Emotional resolution arriving in surges. And bodily sensations interpreted as the brain healing [3].

Participants described dream-like states and a sense of dialogue with the experience, as though with a guide or teacher [3].

Those descriptions come from a specific group, combat veterans with repeated head injuries, and from people who had sought the treatment out. They are what those people reported rather than what anyone should expect.

The accounts were also written on average about thirteen days afterwards, with a range stretching to nearly three months [3]. A description composed weeks later is a memory of an experience shaped by what has happened since, which is a different thing from a record made at the time.

Two further limits are worth noting, and the authors note them. There were two coders and no member checking, meaning participants were not asked whether the themes matched what they meant [3]. And the parent study was open label, so everyone involved knew what had been taken.

The day before

The hours before a session are more structured than people expect, and most of that structure is medical rather than ceremonial.

Someone on opioid maintenance is usually switched to a short-acting opioid beforehand. Both the Dutch study and the 191-person St Kitts series moved participants to oral morphine before dosing [2], because methadone inhibits the enzyme that clears ibogaine and because its long action complicates the timing of withdrawal.

Medications are stopped. In the Stanford protocol that list covered CYP2D6 inhibitors, serotonergic drugs, calcium channel blockers, beta blockers, benzodiazepines, stimulants, corticosteroids and all psychiatric medications [4]. Several of those cannot be stopped abruptly without medical supervision, which is one reason preparation is not a formality.

Baseline measurements are taken. An EKG establishes the starting QT interval, and bloodwork checks potassium, magnesium, liver and kidney function, because each changes what the drug will do.

Fasting is usual before dosing, which combines with the nausea that follows. In the Dutch study participants were admitted and monitored before the dose rather than arriving on the day [2], and in the alcohol pilot participants were hospitalised for 24 to 48 hours beforehand.

Magnesium may be given in advance. The Stanford protocol administered magnesium sulfate intravenously one to two hours before dosing and again about twelve hours after [4].

This is not a guided session

A common assumption, carried over from other psychedelic therapies, is that a therapist works with the person during the experience. In the studied protocols that is not what happens.

In the Stanford study, the session was self-guided and no coaching or psychotherapy took place during dosing [3]. Therapist contact occurred before and after, alongside group preparatory activities and structured integration on the fourth day [4].

The reason is practical. A person who cannot walk unaided, who is nauseated and absorbed in autobiographical recall, is not in a state for conversation. The work is done either side of the session rather than within it.

That shapes what to ask a provider. Staffing during dosing is a medical question about monitoring and emergency capability, while the therapeutic question concerns what happens in the days before and after.

What shapes the experience

Duration and intensity vary between people, and part of that variation has a known cause.

Ibogaine is cleared mainly by the enzyme CYP2D6, and clearance varied more than tenfold across genotype groups in one cohort [5]. Someone who clears it slowly holds higher levels for longer, which lengthens both the experience and the cardiac exposure.

Dose differs between protocols too. The Dutch study used a single 10 milligrams per kilogram dose [2], while the New Zealand providers used staggered doses totalling 25 to 55 milligrams per kilogram over 24 to 96 hours.

Published phase timings therefore describe a central tendency rather than a schedule, and an individual session can run shorter or considerably longer.

Expectation plays a part too, and it is worth naming rather than dismissing. People arrive having read accounts that emphasise visionary content, and the published description puts autobiographical recall at the centre instead. Someone expecting a vision and receiving a review of their own life may find it less transporting and more confronting than they had prepared for.

The setting contributes in a more ordinary way. A room, a mat, eye shades, a monitor attached to the chest and a staff member checking readings is the physical reality behind every account [4]. Descriptions written afterwards tend to omit the equipment, which is part of why the lived experience of the hours can differ from what was imagined.

Where the research goes next

The phase structure rests largely on a retrospective series from non-medical settings, now more than twenty-five years old [1]. Modern prospective description, recorded under monitoring, would be worth having.

Two further questions follow from the pharmacology. Whether the phases track ibogaine and noribogaine concentrations in the way the ataxia does [5], and whether genotype predicts how long someone will be under effects, which would help plan monitoring.

The what to expect page covers the practical arrangements around a stay.

Frequently asked questions

How long does an ibogaine session last?

Intense effects begin one to three hours after the dose and last about four to eight hours, followed by a reflective state of roughly eight to twenty hours [1]. Insomnia often continues for about 72 hours [1].

Can a person walk during treatment?

Generally not. All fourteen patients in the Dutch hospital study developed severe transient ataxia and were unable to walk unaided [2].

Is a therapist present during the session?

In the Stanford protocol, no coaching or psychotherapy took place during dosing; the session was self-guided, with therapist contact before and after [3].

What happens in the days afterwards?

Insomnia often lasts about 72 hours and responds to sleep medication [1]. Cardiac monitoring continues, because the QT interval can remain prolonged after the drug has largely cleared [2], and structured integration activity may be scheduled, as on day four of the Stanford protocol [4].

Is the experience like other psychedelics?

The case series describes panoramic recall of past life events, mostly visual, with hallucinations less prominent than the recalled images [1]. The duration is also far longer than most psychedelics.